Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

667 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
I.v. BU/fludarabine plus melphalan or TBI in unrelated cord blood transplantation for high-risk hematological diseases.
Yamamoto H, Uchida N, Matsuno N, Kon A, Nishida A, Ota H, Ikebe T, Nakano N, Ishiwata K, Araoka H, Takagi S, Tsuji M, Asano-Mori Y, Yamamoto G, Izutsu K, Masuoka K, Wake A, Yoneyama A, Makino S, Taniguchi S. Yamamoto H, et al. Among authors: nakano n. Bone Marrow Transplant. 2015 Apr;50(4):607-9. doi: 10.1038/bmt.2014.316. Epub 2015 Jan 26. Bone Marrow Transplant. 2015. PMID: 25621796 No abstract available.
Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma.
Fuji S, Fujiwara H, Nakano N, Wake A, Inoue Y, Fukuda T, Hidaka M, Moriuchi Y, Miyamoto T, Uike N, Taguchi J, Eto T, Tomoyose T, Kondo T, Yamanoha A, Ichinohe T, Atsuta Y, Utsunomiya A; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation. Fuji S, et al. Among authors: nakano n. Bone Marrow Transplant. 2016 Feb;51(2):205-11. doi: 10.1038/bmt.2015.265. Epub 2015 Nov 2. Bone Marrow Transplant. 2016. PMID: 26524263 Clinical Trial.
GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma.
Muranushi H, Shindo T, Hishizawa M, Tokunaga M, Wake A, Nakano N, Eto T, Hidaka M, Choi I, Miyamoto T, Uchida N, Moriuchi Y, Miyazaki Y, Fukuda T, Ichinohe T, Atsuta Y; ATL Working Group of the Japanese Society for Hematopoietic Cell Transplantation; Kato K. Muranushi H, et al. Among authors: nakano n. Bone Marrow Transplant. 2021 Jan;56(1):155-166. doi: 10.1038/s41409-020-00996-y. Epub 2020 Jul 14. Bone Marrow Transplant. 2021. PMID: 32665675 Free PMC article.
Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics.
Yamasaki S, Mizuno S, Iwasaki M, Seo S, Uchida N, Shigesaburo M, Nakano N, Ishiwata K, Uehara Y, Eto T, Takase K, Kawakita T, Tanaka M, Sawa M, Katayama Y, Nawa Y, Makoto O, Ichinohe T, Atsuta Y, Kanda J, Yanada M. Yamasaki S, et al. Among authors: nakano n. Ann Hematol. 2023 Jun;102(6):1549-1559. doi: 10.1007/s00277-023-05243-0. Epub 2023 May 1. Ann Hematol. 2023. PMID: 37126115
Outcomes in human T-cell leukemia virus type I carriers after hematopoietic stem cell transplantation for diseases other than adult T cell leukemia/lymphoma: a Japanese national survey.
Nakano N, Nakasone H, Fuji S, Shinohara A, Suzuki R, Utsunomiya A, Eto T, Morishima S, Ikegame K, Kakinoki Y, Matsuoka KI, Mori Y, Suehiro Y, Uchida N, Ito A, Doki N, Ozawa Y, Kanda J, Kanda Y, Fukuda T, Atsuta Y, Ogata M. Nakano N, et al. Lancet Reg Health West Pac. 2023 Sep 25;40:100902. doi: 10.1016/j.lanwpc.2023.100902. eCollection 2023 Nov. Lancet Reg Health West Pac. 2023. PMID: 38106528 Free PMC article.
Association of individual comorbidities with outcomes in allogeneic hematopoietic cell transplantation from unrelated adult donors versus unrelated cord blood: A study on behalf of the Donor/Source and Transplant Complications Working Groups of the Japanese Society for Transplantation and Cellular Therapy.
Konuma T, Harada K, Shinohara A, Uchida N, Shingai N, Ito A, Ozawa Y, Tanaka M, Sawa M, Onizuka M, Katayama Y, Hiramoto N, Nakano N, Kimura T, Kanda Y, Fukuda T, Atsuta Y, Nakasone H, Kanda J. Konuma T, et al. Among authors: nakano n. Am J Hematol. 2024 Feb;99(2):263-273. doi: 10.1002/ajh.27174. Epub 2024 Jan 2. Am J Hematol. 2024. PMID: 38164974
Comparison of haploidentical transplantation and single cord blood transplantation for myelofibrosis.
Sakatoku K, Murata M, Shimazu Y, Uchida N, Yoshihara S, Uehara Y, Takahashi S, Kobayashi H, Tanaka H, Nakano N, Ishimaru F, Ichinohe T, Atsuta Y, Nagamura-Inoue T, Nakamae H. Sakatoku K, et al. Among authors: nakano n. Bone Marrow Transplant. 2024 May;59(5):705-707. doi: 10.1038/s41409-024-02244-z. Epub 2024 Feb 20. Bone Marrow Transplant. 2024. PMID: 38378917 No abstract available.
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3.
Levis MJ, Hamadani M, Logan B, Jones RJ, Singh AK, Litzow M, Wingard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Ueda Oshima M, Uy GL, Waller EK, Vasu S, Solh M, Mishra A, Muffly L, Kim HJ, Mikesch JH, Najima Y, Onozawa M, Thomson K, Nagler A, Wei AH, Marcucci G, Geller NL, Hasabou N, Delgado D, Rosales M, Hill J, Gill SC, Nuthethi R, King D, Wittsack H, Mendizabal A, Devine SM, Horowitz MM, Chen YB; BMT-CTN 1506/MORPHO Study Investigators. Levis MJ, et al. J Clin Oncol. 2024 May 20;42(15):1766-1775. doi: 10.1200/JCO.23.02474. Epub 2024 Mar 12. J Clin Oncol. 2024. PMID: 38471061 Free PMC article. Clinical Trial.
667 results